Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation
Authors
Keywords
Atrial fibrillation, Anticoagulation, Catheter ablation, Stroke, Pulmonary vein isolation
Journal
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
Volume 40, Issue 1, Pages 33-38
Publisher
Springer Nature
Online
2014-03-18
DOI
10.1007/s10840-014-9888-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
- (2013) WILLIAM MADDOX et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter
- (2013) Daniel W. Kaiser et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy
- (2012) Michiel Coppens et al. EUROPEAN HEART JOURNAL
- Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
- (2012) Jin-Seok Kim et al. HEART RHYTHM
- A comparison of bleeding complications post-ablation between warfarin and dabigatran
- (2012) David Snipelisky et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
- (2012) Hugh Calkins et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
- (2012) Dhanunjaya Lakkireddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Randomized Controlled Trial of Dabigatran versus Warfarin for Periablation Anticoagulation in Patients Undergoing Ablation of Atrial Fibrillation
- (2012) TAKAMITSU NIN et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
- (2011) Valentin Fuster et al. CIRCULATION
- The Use of Dabigatran Immediately After Atrial Fibrillation Ablation
- (2011) ROGER A. WINKLE et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline)
- (2010) L. Samuel Wann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy
- (2009) Ayman A. Hussein et al. HEART RHYTHM
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started